APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Sexual Dysfunction

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drugs for Sexual Dysfunction Industry Growth and Trends Forecast to 2032

28 December 2025113 pages

Choose your research edition.

Industry ResearchDrugs for Sexual Dysfunction Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Sexual Dysfunction Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Drugs for Sexual Dysfunction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Sexual Dysfunction Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Sexual Dysfunction Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Drugs for Sexual Dysfunction market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drugs for Sexual Dysfunction is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drugs for Sexual Dysfunction is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for Sexual Dysfunction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs for Sexual Dysfunction include Boston Scientific Corporation, CSBio, Dong-A ST, General Factory, Hims, Lilly ICOS LLC, Lupin, Meda Pharmaceuticals and Menarini Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drugs for Sexual Dysfunction market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs for Sexual Dysfunction market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for Sexual Dysfunction market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for Sexual Dysfunction.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drugs for Sexual Dysfunction market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs for Sexual Dysfunction Market by Company

Boston Scientific Corporation

CSBio

Dong-A ST

General Factory

Hims

Lilly ICOS LLC

Lupin

Meda Pharmaceuticals

Menarini Group

Metuchen Pharma

SK Chemicals.

Vivus, Inc.

Bayer AG

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Pfizer Inc

Lilly

Sanofi

Teva Pharmaceutical Industries Ltd.

Drugs for Sexual Dysfunction Segment by Type

Vardenafil (Levitra, Staxyn)

Tadalafil (Cialis)

Udenafil (Zydena)

Sildenafil (Viagra)

Others

Drugs for Sexual Dysfunction Segment by Application

Retail Pharmacies

Online Pharmacies

Hospitals

Clinics

Drugs for Sexual Dysfunction Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Sexual Dysfunction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Sexual Dysfunction and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Sexual Dysfunction.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs for Sexual Dysfunction manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drugs for Sexual Dysfunction in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vardenafil (Levitra, Staxyn) Table 2. Major Company of Tadalafil (Cialis) Table 3. Major Company of Udenafil (Zydena) Table 4. Major Company of Sildenafil (Viagra) Table 5. Major Company of Others Table 6. Global Drugs for Sexual Dysfunction Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 8. Global Drugs for Sexual Dysfunction Sales Market Share in Volume by Type (2021-2026) Table 9. Global Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (US$ Million) Table 10. Global Drugs for Sexual Dysfunction Sales Market Share in Value by Type (2021-2026) Table 11. Global Drugs for Sexual Dysfunction Price by Type (2021-2026) & (US$/Unit) Table 12. Global Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (Units) Table 13. Global Drugs for Sexual Dysfunction Sales Market Share in Volume by Type (2027-2032) Table 14. Global Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (US$ Million) Table 15. Global Drugs for Sexual Dysfunction Sales Market Share in Value by Type (2027-2032) Table 16. Global Drugs for Sexual Dysfunction Price by Type (2027-2032) & (US$/Unit) Table 17. North America Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 18. North America Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 20. Europe Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 22. Asia-Pacific Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 24. Latin America Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 26. Middle East and Africa Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (US$ Million) Table 27. Drugs for Sexual Dysfunction Industry Trends Table 28. Drugs for Sexual Dysfunction Industry Drivers Table 29. Drugs for Sexual Dysfunction Industry Opportunities and Challenges Table 30. Drugs for Sexual Dysfunction Industry Restraints Table 31. Global Drugs for Sexual Dysfunction Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Drugs for Sexual Dysfunction Revenue Market Share by Company (2021-2026) Table 33. Global Drugs for Sexual Dysfunction Sales by Company (2021-2026) & (Units) Table 34. Global Drugs for Sexual Dysfunction Sales Share by Company (2021-2026) Table 35. Global Drugs for Sexual Dysfunction Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Drugs for Sexual Dysfunction Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Drugs for Sexual Dysfunction Major Company Production Sites and Headquarters Table 38. Global Drugs for Sexual Dysfunction Company, Product Type & Application Table 39. Global Drugs for Sexual Dysfunction Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Drugs for Sexual Dysfunction by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Drugs for Sexual Dysfunction Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Drugs for Sexual Dysfunction Sales by Region (2021-2026) & (Units) Table 44. Global Drugs for Sexual Dysfunction Sales Market Share in Volume by Region (2021-2026) Table 45. Global Drugs for Sexual Dysfunction Sales by Region (2021-2026) & (US$ Million) Table 46. Global Drugs for Sexual Dysfunction Sales Market Share in Value by Region (2021-2026) Table 47. Global Drugs for Sexual Dysfunction Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Drugs for Sexual Dysfunction Sales by Region (2027-2032) & (Units) Table 49. Global Drugs for Sexual Dysfunction Sales Market Share in Volume by Region (2027-2032) Table 50. Global Drugs for Sexual Dysfunction Sales by Region (2027-2032) & (US$ Million) Table 51. Global Drugs for Sexual Dysfunction Sales Market Share in Value by Region (2027-2032) Table 52. Global Drugs for Sexual Dysfunction Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Drugs for Sexual Dysfunction Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 55. Global Drugs for Sexual Dysfunction Sales Market Share in Volume by Application (2021-2026) Table 56. Global Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (US$ Million) Table 57. Global Drugs for Sexual Dysfunction Sales Market Share in Value by Application (2021-2026) Table 58. Global Drugs for Sexual Dysfunction Price by Application (2021-2026) & (US$/Unit) Table 59. Global Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (Units) Table 60. Global Drugs for Sexual Dysfunction Sales Market Share in Volume by Application (2027-2032) Table 61. Global Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (US$ Million) Table 62. Global Drugs for Sexual Dysfunction Sales Market Share in Value by Application (2027-2032) Table 63. Global Drugs for Sexual Dysfunction Price by Application (2027-2032) & (US$/Unit) Table 64. North America Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 65. North America Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 67. Europe Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 69. Asia-Pacific Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 71. Latin America Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 73. Middle East and Africa Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (US$ Million) Table 74. Boston Scientific Corporation Company Information Table 75. Boston Scientific Corporation Business Overview Table 76. Boston Scientific Corporation Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Boston Scientific Corporation Drugs for Sexual Dysfunction Product Portfolio Table 78. Boston Scientific Corporation Recent Development Table 79. CSBio Company Information Table 80. CSBio Business Overview Table 81. CSBio Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. CSBio Drugs for Sexual Dysfunction Product Portfolio Table 83. CSBio Recent Development Table 84. Dong-A ST Company Information Table 85. Dong-A ST Business Overview Table 86. Dong-A ST Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Dong-A ST Drugs for Sexual Dysfunction Product Portfolio Table 88. Dong-A ST Recent Development Table 89. General Factory Company Information Table 90. General Factory Business Overview Table 91. General Factory Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. General Factory Drugs for Sexual Dysfunction Product Portfolio Table 93. General Factory Recent Development Table 94. Hims Company Information Table 95. Hims Business Overview Table 96. Hims Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hims Drugs for Sexual Dysfunction Product Portfolio Table 98. Hims Recent Development Table 99. Lilly ICOS LLC Company Information Table 100. Lilly ICOS LLC Business Overview Table 101. Lilly ICOS LLC Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lilly ICOS LLC Drugs for Sexual Dysfunction Product Portfolio Table 103. Lilly ICOS LLC Recent Development Table 104. Lupin Company Information Table 105. Lupin Business Overview Table 106. Lupin Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Lupin Drugs for Sexual Dysfunction Product Portfolio Table 108. Lupin Recent Development Table 109. Meda Pharmaceuticals Company Information Table 110. Meda Pharmaceuticals Business Overview Table 111. Meda Pharmaceuticals Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Meda Pharmaceuticals Drugs for Sexual Dysfunction Product Portfolio Table 113. Meda Pharmaceuticals Recent Development Table 114. Menarini Group Company Information Table 115. Menarini Group Business Overview Table 116. Menarini Group Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Menarini Group Drugs for Sexual Dysfunction Product Portfolio Table 118. Menarini Group Recent Development Table 119. Metuchen Pharma Company Information Table 120. Metuchen Pharma Business Overview Table 121. Metuchen Pharma Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Metuchen Pharma Drugs for Sexual Dysfunction Product Portfolio Table 123. Metuchen Pharma Recent Development Table 124. SK Chemicals. Company Information Table 125. SK Chemicals. Business Overview Table 126. SK Chemicals. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. SK Chemicals. Drugs for Sexual Dysfunction Product Portfolio Table 128. SK Chemicals. Recent Development Table 129. Vivus, Inc. Company Information Table 130. Vivus, Inc. Business Overview Table 131. Vivus, Inc. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Vivus, Inc. Drugs for Sexual Dysfunction Product Portfolio Table 133. Vivus, Inc. Recent Development Table 134. Bayer AG Company Information Table 135. Bayer AG Business Overview Table 136. Bayer AG Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Bayer AG Drugs for Sexual Dysfunction Product Portfolio Table 138. Bayer AG Recent Development Table 139. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Company Information Table 140. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Business Overview Table 141. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Product Portfolio Table 143. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Recent Development Table 144. Pfizer Inc Company Information Table 145. Pfizer Inc Business Overview Table 146. Pfizer Inc Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Pfizer Inc Drugs for Sexual Dysfunction Product Portfolio Table 148. Pfizer Inc Recent Development Table 149. Lilly Company Information Table 150. Lilly Business Overview Table 151. Lilly Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Lilly Drugs for Sexual Dysfunction Product Portfolio Table 153. Lilly Recent Development Table 154. Sanofi Company Information Table 155. Sanofi Business Overview Table 156. Sanofi Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Sanofi Drugs for Sexual Dysfunction Product Portfolio Table 158. Sanofi Recent Development Table 159. Teva Pharmaceutical Industries Ltd. Company Information Table 160. Teva Pharmaceutical Industries Ltd. Business Overview Table 161. Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Product Portfolio Table 163. Teva Pharmaceutical Industries Ltd. Recent Development Table 164. North America Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 165. North America Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 166. North America Drugs for Sexual Dysfunction Sales Market Share by Country (2021-2026) Table 167. North America Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032) & (Units) Table 168. North America Drugs for Sexual Dysfunction Sales Market Share Forecast by Country (2027-2032) Table 169. North America Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. North America Drugs for Sexual Dysfunction Market Size by Country (2021-2026) & (US$ Million) Table 171. North America Drugs for Sexual Dysfunction Market Share by Country (2021-2026) Table 172. North America Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. North America Drugs for Sexual Dysfunction Market Share Forecast by Country (2027-2032) Table 174. Europe Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 175. Europe Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 176. Europe Drugs for Sexual Dysfunction Sales Market Share by Country (2021-2026) Table 177. Europe Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032) & (Units) Table 178. Europe Drugs for Sexual Dysfunction Sales Market Share Forecast by Country (2027-2032) Table 179. Europe Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Europe Drugs for Sexual Dysfunction Market Size by Country (2021-2026) & (US$ Million) Table 181. Europe Drugs for Sexual Dysfunction Market Share by Country (2021-2026) Table 182. Europe Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Europe Drugs for Sexual Dysfunction Market Share Forecast by Country (2027-2032) Table 184. Asia-Pacific Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 185. Asia-Pacific Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 186. Asia-Pacific Drugs for Sexual Dysfunction Sales Market Share by Country (2021-2026) Table 187. Asia-Pacific Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032) & (Units) Table 188. Asia-Pacific Drugs for Sexual Dysfunction Sales Market Share Forecast by Country (2027-2032) Table 189. Asia-Pacific Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Asia-Pacific Drugs for Sexual Dysfunction Market Size by Country (2021-2026) & (US$ Million) Table 191. Asia-Pacific Drugs for Sexual Dysfunction Market Share by Country (2021-2026) Table 192. Asia-Pacific Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Asia-Pacific Drugs for Sexual Dysfunction Market Share Forecast by Country (2027-2032) Table 194. Latin America Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 195. Latin America Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 196. Latin America Drugs for Sexual Dysfunction Sales Market Share by Country (2021-2026) Table 197. Latin America Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032) & (Units) Table 198. Latin America Drugs for Sexual Dysfunction Sales Market Share Forecast by Country (2027-2032) Table 199. Latin America Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Latin America Drugs for Sexual Dysfunction Market Size by Country (2021-2026) & (US$ Million) Table 201. Latin America Drugs for Sexual Dysfunction Market Share by Country (2021-2026) Table 202. Latin America Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Latin America Drugs for Sexual Dysfunction Market Share Forecast by Country (2027-2032) Table 204. Middle East and Africa Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 205. Middle East and Africa Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 206. Middle East and Africa Drugs for Sexual Dysfunction Sales Market Share by Country (2021-2026) Table 207. Middle East and Africa Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032) & (Units) Table 208. Middle East and Africa Drugs for Sexual Dysfunction Sales Market Share Forecast by Country (2027-2032) Table 209. Middle East and Africa Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Middle East and Africa Drugs for Sexual Dysfunction Market Size by Country (2021-2026) & (US$ Million) Table 211. Middle East and Africa Drugs for Sexual Dysfunction Market Share by Country (2021-2026) Table 212. Middle East and Africa Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Middle East and Africa Drugs for Sexual Dysfunction Market Share Forecast by Country (2027-2032) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Drugs for Sexual Dysfunction Distributors List Table 217. Drugs for Sexual Dysfunction Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Drugs for Sexual Dysfunction Image Figure 2. Global Drugs for Sexual Dysfunction Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs for Sexual Dysfunction Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs for Sexual Dysfunction Sales (2021-2032) & (Units) Figure 5. Vardenafil (Levitra, Staxyn) Image Figure 6. Global Vardenafil (Levitra, Staxyn) Sales YoY Growth (2021-2032) & (Units) Figure 7. Tadalafil (Cialis) Image Figure 8. Global Tadalafil (Cialis) Sales YoY Growth (2021-2032) & (Units) Figure 9. Udenafil (Zydena) Image Figure 10. Global Udenafil (Zydena) Sales YoY Growth (2021-2032) & (Units) Figure 11. Sildenafil (Viagra) Image Figure 12. Global Sildenafil (Viagra) Sales YoY Growth (2021-2032) & (Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 15. Global Drugs for Sexual Dysfunction Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Drugs for Sexual Dysfunction Market Share by Type 2025 VS 2032 Figure 17. North America Drugs for Sexual Dysfunction Sales Market Share in Volume by Type in 2025 Figure 18. North America Drugs for Sexual Dysfunction Sales Market Share in Value by Type in 2025 Figure 19. Europe Drugs for Sexual Dysfunction Sales Market Share in Volume by Type in 2025 Figure 20. Europe Drugs for Sexual Dysfunction Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Drugs for Sexual Dysfunction Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Drugs for Sexual Dysfunction Sales Market Share in Value by Type in 2025 Figure 23. Latin America Drugs for Sexual Dysfunction Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Drugs for Sexual Dysfunction Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Drugs for Sexual Dysfunction Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Drugs for Sexual Dysfunction Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Drugs for Sexual Dysfunction Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (Units) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (Units) Figure 33. Hospitals Image Figure 34. Global Hospitals Sales YoY Growth (2021-2032) & (Units) Figure 35. Clinics Image Figure 36. Global Clinics Sales YoY Growth (2021-2032) & (Units) Figure 37. Global Drugs for Sexual Dysfunction Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Drugs for Sexual Dysfunction Market Share by Application 2025 VS 2032 Figure 39. North America Drugs for Sexual Dysfunction Sales Market Share in Volume by Application in 2025 Figure 40. North America Drugs for Sexual Dysfunction Sales Market Share in Value by Application in 2025 Figure 41. Europe Drugs for Sexual Dysfunction Sales Market Share in Volume by Application in 2025 Figure 42. Europe Drugs for Sexual Dysfunction Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Drugs for Sexual Dysfunction Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Drugs for Sexual Dysfunction Sales Market Share in Value by Application in 2025 Figure 45. Latin America Drugs for Sexual Dysfunction Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Drugs for Sexual Dysfunction Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Drugs for Sexual Dysfunction Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Drugs for Sexual Dysfunction Sales Market Share in Value by Application in 2025 Figure 49. North America Drugs for Sexual Dysfunction Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. North America Drugs for Sexual Dysfunction Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Drugs for Sexual Dysfunction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Drugs for Sexual Dysfunction Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Drugs for Sexual Dysfunction Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Europe Drugs for Sexual Dysfunction Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Drugs for Sexual Dysfunction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Drugs for Sexual Dysfunction Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Drugs for Sexual Dysfunction Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Asia-Pacific Drugs for Sexual Dysfunction Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Drugs for Sexual Dysfunction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Drugs for Sexual Dysfunction Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Drugs for Sexual Dysfunction Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 62. Latin America Drugs for Sexual Dysfunction Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Drugs for Sexual Dysfunction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Drugs for Sexual Dysfunction Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Drugs for Sexual Dysfunction Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 66. Middle East and Africa Drugs for Sexual Dysfunction Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Drugs for Sexual Dysfunction Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Drugs for Sexual Dysfunction Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Drugs for Sexual Dysfunction Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Drugs for Sexual Dysfunction Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Vardenafil (Levitra, Staxyn)
  • Tadalafil (Cialis)
  • Udenafil (Zydena)
  • Sildenafil (Viagra)
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals
  • Clinics
Companies covered
  • Boston Scientific Corporation
  • CSBio
  • Dong-A ST
  • General Factory
  • Hims
  • Lilly ICOS LLC
  • Lupin
  • Meda Pharmaceuticals
  • Menarini Group
  • Metuchen Pharma
  • SK Chemicals.
  • Vivus, Inc.
  • Bayer AG
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
  • Pfizer Inc
  • Lilly
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs for Sexual Dysfunction Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drugs for Sexual Dysfunction Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drugs for Sexual Dysfunction Market by Type
  6. 1.3.1 Vardenafil (Levitra, Staxyn)
  7. 1.3.2 Tadalafil (Cialis)
  8. 1.3.3 Udenafil (Zydena)
  9. 1.3.4 Sildenafil (Viagra)
  10. 1.3.5 Others
  11. 1.4 Global Drugs for Sexual Dysfunction Market Size by Type
  12. 1.4.1 Global Drugs for Sexual Dysfunction Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Drugs for Sexual Dysfunction Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Drugs for Sexual Dysfunction Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Drugs for Sexual Dysfunction Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Drugs for Sexual Dysfunction Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Drugs for Sexual Dysfunction Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Drugs for Sexual Dysfunction Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Drugs for Sexual Dysfunction Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drugs for Sexual Dysfunction Industry Trends
  2. 2.2 Drugs for Sexual Dysfunction Industry Drivers
  3. 2.3 Drugs for Sexual Dysfunction Industry Opportunities and Challenges
  4. 2.4 Drugs for Sexual Dysfunction Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drugs for Sexual Dysfunction Revenue (2021-2026)
  2. 3.2 Global Top Players by Drugs for Sexual Dysfunction Sales (2021-2026)
  3. 3.3 Global Top Players by Drugs for Sexual Dysfunction Price (2021-2026)
  4. 3.4 Global Drugs for Sexual Dysfunction Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs for Sexual Dysfunction Major Company Production Sites & Headquarters
  6. 3.6 Global Drugs for Sexual Dysfunction Company, Product Type & Application
  7. 3.7 Global Drugs for Sexual Dysfunction Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs for Sexual Dysfunction Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs for Sexual Dysfunction Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs for Sexual Dysfunction Tier 1, Tier 2, and Tier 3
4 Drugs for Sexual Dysfunction Regional Status and Outlook
  1. 4.1 Global Drugs for Sexual Dysfunction Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drugs for Sexual Dysfunction Historic Market Size by Region
  3. 4.2.1 Global Drugs for Sexual Dysfunction Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drugs for Sexual Dysfunction Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drugs for Sexual Dysfunction Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drugs for Sexual Dysfunction Forecasted Market Size by Region
  7. 4.3.1 Global Drugs for Sexual Dysfunction Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drugs for Sexual Dysfunction Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drugs for Sexual Dysfunction Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drugs for Sexual Dysfunction by Application
  1. 5.1 Drugs for Sexual Dysfunction Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospitals
  5. 5.1.4 Clinics
  6. 5.2 Global Drugs for Sexual Dysfunction Market Size by Application
  7. 5.2.1 Global Drugs for Sexual Dysfunction Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Drugs for Sexual Dysfunction Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Drugs for Sexual Dysfunction Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Drugs for Sexual Dysfunction Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Drugs for Sexual Dysfunction Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Drugs for Sexual Dysfunction Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Drugs for Sexual Dysfunction Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Drugs for Sexual Dysfunction Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boston Scientific Corporation
  2. 6.1.1 Boston Scientific Corporation Company Information
  3. 6.1.2 Boston Scientific Corporation Business Overview
  4. 6.1.3 Boston Scientific Corporation Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boston Scientific Corporation Drugs for Sexual Dysfunction Product Portfolio
  6. 6.1.5 Boston Scientific Corporation Recent Developments
  7. 6.2 CSBio
  8. 6.2.1 CSBio Company Information
  9. 6.2.2 CSBio Business Overview
  10. 6.2.3 CSBio Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSBio Drugs for Sexual Dysfunction Product Portfolio
  12. 6.2.5 CSBio Recent Developments
  13. 6.3 Dong-A ST
  14. 6.3.1 Dong-A ST Company Information
  15. 6.3.2 Dong-A ST Business Overview
  16. 6.3.3 Dong-A ST Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dong-A ST Drugs for Sexual Dysfunction Product Portfolio
  18. 6.3.5 Dong-A ST Recent Developments
  19. 6.4 General Factory
  20. 6.4.1 General Factory Company Information
  21. 6.4.2 General Factory Business Overview
  22. 6.4.3 General Factory Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 General Factory Drugs for Sexual Dysfunction Product Portfolio
  24. 6.4.5 General Factory Recent Developments
  25. 6.5 Hims
  26. 6.5.1 Hims Company Information
  27. 6.5.2 Hims Business Overview
  28. 6.5.3 Hims Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hims Drugs for Sexual Dysfunction Product Portfolio
  30. 6.5.5 Hims Recent Developments
  31. 6.6 Lilly ICOS LLC
  32. 6.6.1 Lilly ICOS LLC Company Information
  33. 6.6.2 Lilly ICOS LLC Business Overview
  34. 6.6.3 Lilly ICOS LLC Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lilly ICOS LLC Drugs for Sexual Dysfunction Product Portfolio
  36. 6.6.5 Lilly ICOS LLC Recent Developments
  37. 6.7 Lupin
  38. 6.7.1 Lupin Company Information
  39. 6.7.2 Lupin Business Overview
  40. 6.7.3 Lupin Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lupin Drugs for Sexual Dysfunction Product Portfolio
  42. 6.7.5 Lupin Recent Developments
  43. 6.8 Meda Pharmaceuticals
  44. 6.8.1 Meda Pharmaceuticals Company Information
  45. 6.8.2 Meda Pharmaceuticals Business Overview
  46. 6.8.3 Meda Pharmaceuticals Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Meda Pharmaceuticals Drugs for Sexual Dysfunction Product Portfolio
  48. 6.8.5 Meda Pharmaceuticals Recent Developments
  49. 6.9 Menarini Group
  50. 6.9.1 Menarini Group Company Information
  51. 6.9.2 Menarini Group Business Overview
  52. 6.9.3 Menarini Group Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Menarini Group Drugs for Sexual Dysfunction Product Portfolio
  54. 6.9.5 Menarini Group Recent Developments
  55. 6.10 Metuchen Pharma
  56. 6.10.1 Metuchen Pharma Company Information
  57. 6.10.2 Metuchen Pharma Business Overview
  58. 6.10.3 Metuchen Pharma Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Metuchen Pharma Drugs for Sexual Dysfunction Product Portfolio
  60. 6.10.5 Metuchen Pharma Recent Developments
  61. 6.11 SK Chemicals.
  62. 6.11.1 SK Chemicals. Company Information
  63. 6.11.2 SK Chemicals. Business Overview
  64. 6.11.3 SK Chemicals. Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SK Chemicals. Drugs for Sexual Dysfunction Product Portfolio
  66. 6.11.5 SK Chemicals. Recent Developments
  67. 6.12 Vivus, Inc.
  68. 6.12.1 Vivus, Inc. Company Information
  69. 6.12.2 Vivus, Inc. Business Overview
  70. 6.12.3 Vivus, Inc. Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Vivus, Inc. Drugs for Sexual Dysfunction Product Portfolio
  72. 6.12.5 Vivus, Inc. Recent Developments
  73. 6.13 Bayer AG
  74. 6.13.1 Bayer AG Company Information
  75. 6.13.2 Bayer AG Business Overview
  76. 6.13.3 Bayer AG Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bayer AG Drugs for Sexual Dysfunction Product Portfolio
  78. 6.13.5 Bayer AG Recent Developments
  79. 6.14 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
  80. 6.14.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Company Information
  81. 6.14.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Business Overview
  82. 6.14.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Product Portfolio
  84. 6.14.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Recent Developments
  85. 6.15 Pfizer Inc
  86. 6.15.1 Pfizer Inc Company Information
  87. 6.15.2 Pfizer Inc Business Overview
  88. 6.15.3 Pfizer Inc Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Pfizer Inc Drugs for Sexual Dysfunction Product Portfolio
  90. 6.15.5 Pfizer Inc Recent Developments
  91. 6.16 Lilly
  92. 6.16.1 Lilly Company Information
  93. 6.16.2 Lilly Business Overview
  94. 6.16.3 Lilly Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Lilly Drugs for Sexual Dysfunction Product Portfolio
  96. 6.16.5 Lilly Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sanofi Drugs for Sexual Dysfunction Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Teva Pharmaceutical Industries Ltd.
  104. 6.18.1 Teva Pharmaceutical Industries Ltd. Company Information
  105. 6.18.2 Teva Pharmaceutical Industries Ltd. Business Overview
  106. 6.18.3 Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Product Portfolio
  108. 6.18.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Drugs for Sexual Dysfunction Sales by Country
  2. 7.1.1 North America Drugs for Sexual Dysfunction Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drugs for Sexual Dysfunction Sales by Country (2021-2026)
  4. 7.1.3 North America Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drugs for Sexual Dysfunction Market Size by Country
  6. 7.2.1 North America Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drugs for Sexual Dysfunction Market Size by Country (2021-2026)
  8. 7.2.3 North America Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drugs for Sexual Dysfunction Sales by Country
  2. 8.1.1 Europe Drugs for Sexual Dysfunction Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drugs for Sexual Dysfunction Sales by Country (2021-2026)
  4. 8.1.3 Europe Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drugs for Sexual Dysfunction Market Size by Country
  6. 8.2.1 Europe Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drugs for Sexual Dysfunction Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drugs for Sexual Dysfunction Sales by Country
  2. 9.1.1 Asia-Pacific Drugs for Sexual Dysfunction Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drugs for Sexual Dysfunction Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drugs for Sexual Dysfunction Market Size by Country
  6. 9.2.1 Asia-Pacific Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drugs for Sexual Dysfunction Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drugs for Sexual Dysfunction Sales by Country
  2. 10.1.1 South America Drugs for Sexual Dysfunction Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drugs for Sexual Dysfunction Sales by Country (2021-2026)
  4. 10.1.3 South America Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drugs for Sexual Dysfunction Market Size by Country
  6. 10.2.1 South America Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drugs for Sexual Dysfunction Market Size by Country (2021-2026)
  8. 10.2.3 South America Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drugs for Sexual Dysfunction Sales by Country
  2. 11.1.1 Middle East and Africa Drugs for Sexual Dysfunction Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drugs for Sexual Dysfunction Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drugs for Sexual Dysfunction Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drugs for Sexual Dysfunction Market Size by Country
  6. 11.2.1 Middle East and Africa Drugs for Sexual Dysfunction Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drugs for Sexual Dysfunction Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drugs for Sexual Dysfunction Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drugs for Sexual Dysfunction Value Chain Analysis
  2. 12.1.1 Drugs for Sexual Dysfunction Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drugs for Sexual Dysfunction Production Mode & Process
  7. 12.2 Drugs for Sexual Dysfunction Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drugs for Sexual Dysfunction Distributors
  10. 12.2.3 Drugs for Sexual Dysfunction Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst